Fennec Pharmaceuticals (FENC) Competitors

CARGO Therapeutics (NASDAQ:CRGX) and Fennec Pharmaceuticals (NASDAQ:FENC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment and dividends.

Does the media refer more to CRGX or FENC?

In the previous week, Fennec Pharmaceuticals had 11 more articles in the media than CARGO Therapeutics. MarketBeat recorded 15 mentions for Fennec Pharmaceuticals and 4 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 0.39 beat Fennec Pharmaceuticals' score of 0.30 indicating that CARGO Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CARGO Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fennec Pharmaceuticals	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts rate CRGX or FENC?

CARGO Therapeutics presently has a consensus target price of $31.80, suggesting a potential upside of 113.42%. Fennec Pharmaceuticals has a consensus target price of $13.67, suggesting a potential upside of 128.16%. Given Fennec Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Fennec Pharmaceuticals is more favorable than CARGO Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CARGO Therapeutics	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Is CRGX or FENC more profitable?

CARGO Therapeutics has a net margin of 0.00% compared to Fennec Pharmaceuticals' net margin of -2.30%. CARGO Therapeutics' return on equity of -38.16% beat Fennec Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CARGO Therapeutics	N/A	-38.16%	-33.94%
Fennec Pharmaceuticals	-2.30%	-53.38%	-2.08%

Do insiders & institutionals believe in CRGX or FENC?

93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 55.5% of Fennec Pharmaceuticals shares are owned by institutional investors. 1.4% of CARGO Therapeutics shares are owned by company insiders. Comparatively, 11.0% of Fennec Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer CRGX or FENC?

Fennec Pharmaceuticals received 186 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 66.45% of users gave Fennec Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
CARGO Therapeutics	Outperform Votes 14 100.00%	Underperform Votes No Votes
Fennec Pharmaceuticals	Outperform Votes 200 66.45%	Underperform Votes 101 33.55%

Which has preferable valuation and earnings, CRGX or FENC?

Fennec Pharmaceuticals has higher revenue and earnings than CARGO Therapeutics. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CARGO Therapeutics	N/A	N/A	-$98.15M	-$4.26	-3.50
Fennec Pharmaceuticals	$49.35M	3.33	-$16.05M	-$0.10	-59.90

Summary

Fennec Pharmaceuticals beats CARGO Therapeutics on 10 of the 17 factors compared between the two stocks.